New MoA in RA 🚨 Dual inhibition BAFF/BLys Telalicept MTX IR pts Ph3 vs. PBO ACR20 60 vs. 27% ACR50 21 vs. 6% DAS28
Tweet Content
New MoA in RA 🚨
Dual inhibition BAFF/BLys Telalicept MTX IR pts Ph3 vs. PBO
ACR20 60 vs. 27%
ACR50 21 vs. 6%
DAS28<3.2 15 vs. 5%
Less Rx prog
Safety similar infection rates
@RheumNow #ACR23 ABSTL20 https://t.co/WHysLSKyo0
Show on Archive Page
On
Display in Search Results
On
PDQ
Off